Root, 1999 - Google Patents
Clinical infectious diseases: a practical approachRoot, 1999
View PDF- Document ID
- 13766719497369073053
- Author
- Root R
- Publication year
External Links
Snippet
Until now, those in need of information on infectious diseases had to choose between encyclopedic reference texts or the infectious diseases sections in standard textbooks in internal medicine. Now there is a better alternative-Clinical Infectious Diseases fills the long …
- 201000009910 diseases by infectious agent 0 title abstract description 188
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Root | Clinical infectious diseases: a practical approach | |
| Wilson | The hazards of immunization | |
| Herzog | History of tuberculosis | |
| Cohen et al. | Pneumonic plague in an untreated plague-vaccinated individual | |
| Hawgood | Albert Calmette (1863–1933) and Camille Guerin (1872–1961): the C and G of BCG vaccine | |
| Hughes et al. | Infectious diseases in children with cancer | |
| Strong | Typhus fever with particular reference to the Serbian epidemic | |
| Guckian et al. | Arizona infection of man: report of a case and review of the literature | |
| Zubair et al. | A review on laboratory investigation of anthrax as causative infectious disease and future perspectives | |
| Ørskov et al. | Studies on the significance of “Vi Antigen” in the Mechanism of Typhoid Infection in Mice | |
| Harris | Howard Florey and the development of penicillin | |
| Stimson | A brief history of bacteriological investigations of the United States Public Health Service | |
| Lugoboni et al. | Hepatitis A virus vaccination among injecting drug users: do we have to change the vaccination schedule? | |
| Curtis et al. | Hot topics in infection and immunity in children VII | |
| Whitmore et al. | Pasteurella septica meningitis with survival | |
| Coates et al. | Internal Medicine in World War II.: Infectious diseases | |
| Parry | Typhoid fever and cholera | |
| Hahon | Selected papers on the pathogenic rickettsiae | |
| Symmers | Torulosis and Hodgkin's disease | |
| Chubak | Plague first struck Europe in 541, in an epidemic called Justinian's Plague after the Byzantine emperor who ruled at the time of the outbreak. It began in Egypt | |
| Newsom | The history of infection control: Tuberculosis: Part two—Finding the cause and trying to eliminate it | |
| Wani et al. | Tuberculosis, Challenges and Status with Special Reference to Jammu and Kashmir: A Way Forward | |
| Gangarosa et al. | Search for a mass chemotherapeutic drug for cholera control: A study of vibrio excretion following single and multiple dose treatment | |
| Sodeman | Amebiasis | |
| Machakanur | A clinical trial of treatment of uncomplicated typhoid fever: efficacy of azithromycin versus ceftriaxone |